Individualizing the Approach to Stopping Nucleos(t)ide Analogs: Can We Use a Low HBsAg Threshold to Predict a High Chance of Functional Cure and Minimal Risk of Hepatic Decompensation?
Am J Gastroenterol. 2024 Apr 15.
doi: 10.14309/ajg.0000000000002766.
Online ahead of print.
1 St Vincent's Hospital Melbourne, Melbourne, Australia.
2 University of Melbourne, Melbourne, Australia.
3 Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital and Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.